Abciximab Biosimilar - Anti-ITGA2B_ITGB3 mAb - Research Grade
Source
CAS 143653-53-6
Species
Chimeric
Expression system
Mammalian cells
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Abciximab,c7E3,ITGA2B_ITGB3,anti-ITGA2B_ITGB3
Reference
PX-TA1104
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
Fab-G1-kappa
Clonality
Monoclonal Antibody
Description of Abciximab Biosimilar - Anti-ITGA2B_ITGB3 mAb - Research Grade
General information on Anti-ITGA2B_ITGB3(Homo sapiens) (Abciximab) Monoclonal Antibody
Abciximab is the Fab fragment of the chimeric human mouse monoclonal antibody 7E3. Abciximab binds to human platelet glycoprotein (GP) IIb/IIIa receptors and inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor and other adhesion molecules. It also binds to vitronectin (alpha v beta 3) receptors found on platelets, vascular wall endothelial cells and smooth muscle cells.
SDS-PAGE for Abciximab Biosimilar - Anti-ITGA2B_ITGB3 mAb
Abciximab Biosimilar - Anti-ITGA2B_ITGB3 mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Abciximab Biosimilar – Anti-ITGA2B_ITGB3 mAb – Research Grade” Cancel reply
Reviews
There are no reviews yet.